News
MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: We’re at an Inflection Point
MedX Holdings, Inc. (OTC: MEDH) Med-X Holdings Q2 2025 Investor Update: We’re at an Inflection Point Sales up; on track for ~$1.5M FY25 revenue. Las Vegas lounge approaching approvals. Leaf-trak POS ...
WARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN) announced its financial results for the fiscal quarter ended June 30, 2025, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback